Gubra

Gubra is a leading biotechnology research company committed to advancing scientific discovery and improving global health. Since its founding in 2008, Gubra has been dedicated to providing exceptional preclinical contract research organization (CRO) services and developing innovative, proprietary early target and drug discovery programs. Located at Hørsholm Kongevej 11b, Hoersholm, 2970, DK, Gubra operates with a focus on excellence and collaboration.

Gubra specializes in the metabolic space, addressing critical areas such as obesity, diabetes, NASH, and gastrointestinal diseases. Their expertise encompasses peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next-generation sequencing), and bioinformatics. Gubra's commitment to high quality, scientific rigor, and teamwork has solidified its reputation as a trusted partner in the pharmaceutical, biotech, and academic sectors worldwide.

Gubra's dedication to innovation and scientific advancement makes it a key player in the biotechnology landscape. Gubra looks forward to continuing its mission of driving impactful research and contributing to significant breakthroughs in healthcare. We invite Gubra's management team to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.